Lakewood Amedex - Crunchbase Company Profile & Funding

Q: Who invested in Lakewood Amedex?

Lakewood Amedex is funded by Scarsdale Equities.

Q: When was the last funding round for Lakewood Amedex?

Lakewood Amedex closed its last funding round on obfuscated from a Venture - Series Unknown round.

Q: How much funding has Lakewood Amedex raised to date?

Lakewood Amedex has raised obfuscated.

Overview

Lakewood Amedex

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

+2 more milestones

See more interactive data and historical milestones on desktop for the best experience

About Lakewood Amedex

CB Rank

6223

Lakewood-Amedex focuses on developing novel-approach anti-infective products in the treatment of serious infectious diseases.

Founded

obfuscation

Public

Venture - Series Unknown

Sarasota, Florida, United States

11-50

www.lakewoodamedex.com/

Biopharma

Biotechnology

Health Care

Funding Rounds

Venture - Series Unknown

OBF

obfuscation

Series C

OBF

obfuscation

Key People

Steve Parkinson: Board Member and Consultant
Doug Manion: Director
Past Role: Celleron Therapeutics, Director

Details

Legal Name

Lakewood-Amedex, Inc.

Operating Status

Active

Stock Symbol

NASDAQ:LABT

Company Type

For Profit

About the Company

Lakewood-Amedex is a biopharmaceutical company that focuses on developing novel-approach anti-infective products in the treatment of serious infectious diseases. The Company's products and technology are covered by an extensive patent portfolio consisting of 74 issued and 13 pending patents.

It was founded in 2006 and headquartered in

Sarasota, Florida.

Phone Number

(941)225-2511

Contact Email

info@lakewoodamedex.com

Predictions & Insights

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Key Employee Changes

Products & Services

Bisphosphocins™

A class of antimicrobial compounds that disrupt microbial cell membranes to rapidly kill bacteria and fungi at the infection site.

Nu-3 Gel

A topical gel formulation of Bisphosphocins™ developed for treating infected diabetic foot ulcers (iDFU).

Research & Development

Lakewood Amedex is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Lakewood Amedex	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Lakewood Amedex	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Lakewood Amedex	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Lakewood Amedex	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Lakewood Amedex	—	obfuscated obfuscation	—	Venture - Series Unknown

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Lakewood Amedex	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Lakewood Amedex	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Lakewood Amedex	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Lakewood Amedex	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Lakewood Amedex	—	obfuscated obfuscation	—	Venture - Series Unknown

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Scarsdale Equities	Yes	Series C - Lakewood Amedex	—
Scarsdale Equities	Yes	Series C - Lakewood Amedex	—
Scarsdale Equities	Yes	Series C - Lakewood Amedex	—
Scarsdale Equities	Yes	Series C - Lakewood Amedex	—
Scarsdale Equities	Yes	Series C - Lakewood Amedex	—